• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入特布他林的肺部沉积:扫描γ相机与尿排泄方法的比较。

Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods.

作者信息

Borgström L, Newman S, Weisz A, Morén F

机构信息

Department of Human Pharmacology, Astra Draco, Lund, Sweden.

出版信息

J Pharm Sci. 1992 Aug;81(8):753-5. doi: 10.1002/jps.2600810807.

DOI:10.1002/jps.2600810807
PMID:1403719
Abstract

Deposition from a multidose powder inhaler (Turbuhaler, Astra) delivering 500 micrograms of terbutaline sulfate per metered dose was compared by two techniques in a group of six healthy volunteers. The deposition of the radionuclide 99mTc, which was used to label terbutaline sulfate powder, was quantified by gamma camera (G-method). Simultaneously, the gastrointestinal absorption of swallowed drug was blocked with activated charcoal, and the amount of terbutaline in a urine sample, collected over a period of 48 h and corrected by a pharmacokinetic internal standard of intravenous deuterated terbutaline, was used as a measure of lung deposition (U-method). The mean (standard deviation) depositions in lung were 26.9 (3.8%) of the dose for the G-method and 21.1 (3.2)% of the dose for the U-method. Possible reasons for the differences between the two means are discussed. Both methods are suitable for assessing deposition from medical aerosol inhalers; the U-method requires access to gas chromatography-mass spectrometric equipment, and the G-method requires access to gamma camera facilities.

摘要

采用两种技术,在6名健康志愿者中比较了多剂量粉末吸入器(都保,阿斯特拉公司),其每揿剂量为500微克硫酸特布他林的药物沉积情况。用放射性核素99mTc标记硫酸特布他林粉末,通过γ相机(G法)对其沉积进行定量分析。同时,用活性炭阻断吞咽药物的胃肠道吸收,收集48小时尿液样本中的特布他林量,并通过静脉注射氘代特布他林的药代动力学内标进行校正,以此作为肺沉积的量度(U法)。G法肺内平均(标准差)沉积量为剂量的26.9(3.8)%,U法为剂量的21.1(3.2)%。讨论了两种平均值之间差异的可能原因。两种方法均适用于评估医用气雾剂吸入器的沉积情况;U法需要使用气相色谱-质谱设备,G法需要使用γ相机设备。

相似文献

1
Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods.吸入特布他林的肺部沉积:扫描γ相机与尿排泄方法的比较。
J Pharm Sci. 1992 Aug;81(8):753-5. doi: 10.1002/jps.2600810807.
2
Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler.
Pharm Res. 1995 Feb;12(2):231-6. doi: 10.1023/a:1016278926231.
3
Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.通过都保吸入的布地奈德在肺部的沉积:与硫酸特布他林在正常受试者中的比较。
Eur Respir J. 1994 Jan;7(1):69-73. doi: 10.1183/09031936.94.07010069.
4
Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion.特布他林吸入后经尿排泄的肺相对生物利用度。
Br J Clin Pharmacol. 2011 Apr;71(4):608-10. doi: 10.1111/j.1365-2125.2010.03873.x.
5
A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline.一种测定吸入药物(特布他林)绝对肺生物利用度的方法。
Pharm Res. 1990 Oct;7(10):1068-70. doi: 10.1023/a:1015951402799.
6
Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.在不同条件下,通过 Turbuhaler 吸入特布他林的发射剂量和肺部沉积。
Respir Med. 2010 May;104(5):682-9. doi: 10.1016/j.rmed.2009.11.014. Epub 2009 Dec 8.
7
Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler.
Eur Respir J. 1989 Mar;2(3):247-52.
8
Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals.
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1398-402. doi: 10.1164/ajrccm.164.8.2101010.
9
The inhalation device influences lung deposition and bronchodilating effect of terbutaline.吸入装置会影响特布他林的肺部沉积和支气管扩张效果。
Am J Respir Crit Care Med. 1996 May;153(5):1636-40. doi: 10.1164/ajrccm.153.5.8630614.
10
Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.特布他林对哮喘患者和健康受试者通过定量吸入器和干粉吸入器吸入药物后黏液纤毛清除功能的影响。
Thorax. 1991 Nov;46(11):817-23. doi: 10.1136/thx.46.11.817.

引用本文的文献

1
Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations.用于干粉吸入制剂冻干品的放射性标记方法。
Pharmaceutics. 2022 Mar 31;14(4):759. doi: 10.3390/pharmaceutics14040759.
2
Evaluating Drug Deposition Patterns from Turbuhaler® in Healthy and Diseased Lung Models of Preschool Children.评估都保装置在学龄前儿童健康和患病肺部模型中的药物沉积模式。
J Pulm Med Respir Care. 2022;4(1).
3
Deposition and effects of inhaled corticosteroids.吸入性糖皮质激素的沉积与作用
Clin Pharmacokinet. 2003;42(6):529-44. doi: 10.2165/00003088-200342060-00003.
4
Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization.雾化吸入后沙丁胺醇在肺部与体循环中的相对生物利用度测定。
Br J Clin Pharmacol. 2002 Aug;54(2):115-9. doi: 10.1046/j.1365-2125.2002.01632.x.
5
Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder.使用工程化肺球体粉末的被动干粉吸入器改善肺部给药。
Pharm Res. 2002 May;19(5):689-95. doi: 10.1023/a:1015322616613.
6
Methods to identify drug deposition in the lungs following inhalation.识别吸入后药物在肺部沉积的方法。
Br J Clin Pharmacol. 2001 Apr;51(4):289-99. doi: 10.1046/j.1365-2125.2001.01304.x.
7
Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?肺部沉积数据能否作为吸入性哮喘药物临床反应的替代指标?
Br J Clin Pharmacol. 2000 Jun;49(6):529-37. doi: 10.1046/j.1365-2125.2000.00106.x.
8
Methods to determine lung distribution of inhaled drugs - could gamma scintigraphy be the gold standard?确定吸入药物肺部分布的方法——γ闪烁显像能否成为金标准?
Br J Clin Pharmacol. 2000 Jun;49(6):525-8. doi: 10.1046/j.1365-2125.2000.00215.x.
9
Particle size selection device for use with the Turbohaler.与都保配合使用的粒径选择装置。
Thorax. 1996 May;51(5):537-9. doi: 10.1136/thx.51.5.537.
10
Standards for bioequivalence of inhaled products.吸入制剂的生物等效性标准。
Clin Pharmacokinet. 1994 Jan;26(1):1-6. doi: 10.2165/00003088-199426010-00001.